Liminatus Pharma, Inc. - Class A (LIMN)
NASDAQ · Healthcare
$0.11-7.24%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 8,177,560
- 52-week high
- —
- 52-week low
- —
- Open
- $0.12
- Day high
- $0.12
- Day low
- $0.11
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | — | -$10.21M | -$0.43 |
| 2024 | — | -$3.55M | -$0.20 |
About Liminatus Pharma, Inc. - Class A
Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.
- CEO
- Chris Kim
- Employees
- 3
- Country
- US
- IPO date
- May 1, 2025
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is Liminatus Pharma, Inc. - Class A's stock price today?
- LIMN is trading at $0.11 as of Jul 20, 2026.
- Does Liminatus Pharma, Inc. - Class A pay a dividend?
- Liminatus Pharma, Inc. - Class A did not pay a dividend in its most recent reported fiscal year.
- What sector is Liminatus Pharma, Inc. - Class A in?
- Liminatus Pharma, Inc. - Class A operates in the Healthcare sector.